Invesco India Large & Mid Cap Fund - Growth
Category: Equity: Large and Mid Cap
Launch Date: 09-08-2007
AUM:
₹ 9,761.15 Cr
Expense Ratio
1.9%
Benchmark
NIFTY Large Midcap 250 TRI
ISIN
INF205K01247
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
100
Fund Manager
Aditya Khemani
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Invesco India Large & Mid Cap Fund - Growth | 3.14 | 22.1 | 16.78 |
| NIFTY LARGE MIDCAP 250 TRI | 1.48 | 16.16 | 14.26 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
100.93
Last change
0.38 (0.3765%)
Fund Size (AUM)
₹ 9,761.15 Cr
Performance
13.06% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme aims to generate long-term capital growth by investing predominantly in equity and equity related securities following a bottom-up approach in selecting stocks depending on their market-cap and sector.
Fund Manager
Aditya Khemani
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.07 |
| ZOMATO LIMITED EQ | 6.26 |
| INTERGLOBE AVIATION LIMITED EQ NEW FV RS. 10/- | 6.12 |
| ICICI BANK LIMITED EQ NEW FV RS. 2/- | 5.99 |
| Sai Life Sciences Limited | 4.69 |
| TRENT LIMITED EQ NEW FV Re. 1/- | 4.62 |
| PRESTIGE ESTATES PROJECTS LIMITED EQ | 4.54 |
| BSE LIMITED EQ NEW FV RS. 2/- | 4.12 |
| ABB INDIA LIMITED EQ NEW RS. 2/- | 3.44 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.31 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Financial Services | 29.22 |
| Healthcare | 19.13 |
| Consumer Services | 12.8 |
| Capital Goods | 9.25 |
| Realty | 7.32 |
| Services | 6.5 |
| Consumer Durables | 4.52 |
| Construction Materials | 3.85 |
| Information Technology | 2.55 |
| Telecommunication | 1.84 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Invesco India Large and Mid Cap Gr | 16.78 |